Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 1, 2008, Pages 105-112

  Oshima, Toru ^a   Sonoda, Koh Hei ^a   Nakao, Shintaro ^a   Hijioka, Kuniaki ^a   Taniguchi, Masaru ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CD1 ANTIGEN; CELL SURFACE RECEPTOR; MESSENGER RNA; SILVER NITRATE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ARTICLE; CAUTERIZATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; KERATITIS; MOUSE; NATURAL KILLER T CELL; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CORNEA EDEMA; CORNEA OPACITY; FLOW CYTOMETRY; GENETICS; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1; CORNEAL EDEMA; CORNEAL OPACITY; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE II; KERATITIS; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SILVER NITRATE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 39549107977     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0284     Document Type: Article

References (40)

1. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3:879-889.
2. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
3. Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 1992;11:1199-1206.
4. Taylor AW, Streilein JW, Cousins SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol. 1994;153:1080-1086.
5. Hazlett LD. Role of innate and adaptive immunity in the pathogenesis of keratitis. Ocul Immunol Inflamm. 2005;13:133-138.
6. Dana MR. Angiogenesis and lymphangiogenesis: implications for corneal immunity. Semin Ophthalmol. 2006;21:19-22.
7. Sonoda KH, Nakao S, Nakamura T, et al. Cellular events in the normal and inflamed cornea. Cornea. 2005;24:S50-S54.
8. Oshima T, Sonoda KH, Tsutsumi-Miyahara C, et al. Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice. Br J Ophthalmol. 2006;90:218-222.
9. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol. 1997;15:535-562.
10. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol. 2003;21:483-513.
11. - T cells in mice and humans. J Exp Med. 1994;180:1097-1106.
12. Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M. Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Intl Immunol. 1995;7:1157-1161.
13. -α/β T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med. 1993;178:1-16.
14. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR. CD1 recognition by mouse NK1+ T lymphocytes. Science. 1995;268:863-865.
15. - T cells. J Exp Med. 1997;186:109-120.
16. Chen YH, Chiu NM, Mandal M, Wang N, Wang CR. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity. 1997;6:459-467.
17. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 1997;6:469-477.
18. Smiley ST, Kaplan MH, Grusby MJ. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science. 1997;275:977-979.
19. Cui J, Shin T, Kawano T, et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 1997;278:1623-1626.
20. Ito K, Karasawa M, Kawano T, et al. Involvement of decidual Vα14 NKT cells in abortion. Proc Natl Acad Sci USA. 2000;97:740-744.
21. - T cells with a skewed variable region repertoire after infection with Listeria monocytogenes. Eur J Immunol. 1995;25:1985-1991.
22. Apostolou I, Takahama Y, Belmant C, et al. Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA. 1999;96:5141-5146.
23. Sumida T, Sakamoto A, Murata H, et al. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med. 1995;182:1163-1168.
24. - T-cell deficiency and IDDM in NOD/Lt mice. Diabetes. 1997;46:572-582.
25. Seino KI, Fukao K, Muramoto K, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA. 2001;98:2577-2581.
26. Iwai T, Tomita Y, Okano S, et al. Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance. J Immunol. 2006;177:8400-8409.
27. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol. 1993;150:1727-1734.
28. Sonoda KH, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol. 2002;168:2028-2034.
29. Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site [see comments]. J Exp Med. 1999;190:1215-1226.
30. Sonoda K, Sakamoto T, Yoshikawa H, et al. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization. Invest Ophthalmol Vis Sci. 1998;39:2245-2251.
31. Seo SK, Gebhardt BM, Lim HY, et al. Murine keratocytes function as antigen-presenting cells. Eur J Immunol. 2001;31:3318-3328.
32. Kuwano T, Nakao S, Yamamoto H, et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 2004;18:300-310.
33. Nakao S, Kuwano T, Tsutsumi-Miyahara C, et al. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 betainduced neovascularization and tumor growth. J Clin Invest. 2005;115:2979-2991.
34. Jiang X, Shimaoka T, Kojo S, et al. Critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol. 2005;175:2051-2055.
35. Oakes JE, Monteiro CA, Cubitt CL, Lausch RN. Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells. J Virol. 1993;67:4777-4784.
36. Diao H, Kon S, Iwabuchi K, et al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity. 2004;21:539-550.
37. Hazlett LD, Li Q, Liu J, et al. NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice. J Immunol. 2007;179:1138-1146.
38. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2006;25:297-336.
39. Lee YC. The involvement of VEGF in endothelial permeability: a target for anti-inflammatory therapy. Curr Opin Investig Drugs. 2005;6:1124-1130.
40. Hwang SJ, Kim S, Park WS, Chung DH. IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils. J Immunol. 2006;177:5258-5268.